Safety, Tolerability, and Immunogenicity of VAL-181388 in Healthy Participants
Clinical trial NCT03325075 · COMPLETED
Trial details
- NCT number
- NCT03325075
- Sponsor
- ModernaTX, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-19
- Primary completion
- 2019-03-19
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.